Digital therapeutics can be defined as a health discipline and treatment option that utilizes digital and often online health technologies to treat a medical or psychological condition. Digital therapeutics provide a new approach to treatment and disease management in which digital systems help patients manage their own health and disease conditions. Digital therapeutics utilize the infrastructure of the Internet, mobile phone, and the novel gains in artificial intelligence, machine learning, and big data analytics to optimize treatment for a given individual, thereby embracing the principle of personalized medicine. Digital therapeutics includes a vast range of product types, including apps, wearable devices, and telemedicine platforms, etc. There are thousands of health app and wearable device available across the globe.

Increasing use of smartphones and growing number of internet users, the need to curb healthcare expenditures, advancement and miniaturization of digital technologies are some factors that are attributing to increasing adoption of digital therapeutics among consumers. Trends such as Government initiative and venture capital funding are also fuelling the growth of digital therapeutics market during the forecast period. Moreover, rising preventive healthcare practices, digitalization of healthcare and effective management of chronic diseases are supporting the growth of the market during forecast period. Furthermore, improved drug adherence, ability to induce Behavioral changes and patient convenience are such benefits offered by digital therapeutics which act as a driving force for the growth of digital therapeutics market. However, lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns are the major restraining factors for the growth of the digital therapeutics market.

Various notable players operating in the market, include Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Livongo Health, Noom Inc., Ginger.Io, Inc., Propeller Health, 2morrow Inc., Canary Health Inc., Mango Health Inc. among others. Major players are focussing on merger and strategic collaboration to expand their business across the globe. For instance, in 2018, Proteus Digital Health entered into a strategic partnership with Otsuka Pharmaceutical to manufacture Abilify MyCite.

The global digital therapeutics market report has been segmented on the basis of product type, application, and key geographies. Based on product type, the market comprises Hardware {Wearable Device and Non-wearable Device} and Software). The research report “global digital therapeutics market” provides in-depth analysis of global digital therapeutics market based on product type, application, and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides growth, opportunity, market size, trends and forecast for the global digital therapeutics market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The market outlook and competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace is digital therapeutics market growing? What will be the global digital therapeutics Market forecast?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in digital therapeutics and global digital therapeutics market size?
4- Global digital therapeutics market outlook, application areas and how they are poised to grow?
5- Global digital therapeutics market overview, industry analysis and scope of study?

Market Segmentation
By Product Type
• Hardware
o Wearable Device
■ Headbands
■ Smart Watches
■ Sociometric Badges
■ Others
o Non-wearable Device
■ Glucose Monitoring Devices
■ Others
• Software

By Application
• Preventive
o Prediabetes
o Obesity
• Treatment
o Diabetes
o Obesity
o CVD
o CNS Disease
o Respiratory Diseases
o Smoking Cessation
o Others

By Geography
• North America
As a part of customization
o By Product Type
o By Application
o US
o Canada
o Mexico

• Europe
As a part of customization
o By Product Type
o By Application
o UK
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Product Type
o By Application
o China
o Australia
o India
o Rest of APAC

• ROW
As a part of customization
o By Product Type
o By Application
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)

Leading market players
• Proteus Digital Health, Inc.
• Omada Health, Inc.
• Welldoc, Inc.
• Livongo Health
• Noom Inc.
• Ginger.Io, Inc.
• Propeller Health
• 2morrow Inc.
• Canary Health Inc.
• Mango Health Inc

*Other prominent players in the market which can be profiled as a part of customization:
• Twinehealth